Halo logo
Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
EH
Elaine Hamm
CEO
Ascendis Pharma
Work experience
Ascendis Pharma
CEO
Ascend Bioventures
CEO
Top industry applications
Neurology & neurological diseasePharmaceuticals and drug delivery
Expertise
AntimicrobialsArtificial IntelligenceBiopharmaceuticsNeurodegenerationRegenerative Medicine
Last updated Aug 2023
the therapeutic implications of all in one aav delivered epigenome editing platform in neurodegenerative disorders
Nature Comms
•
2024
The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT V
J Alzheimers Dis .
APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's
Int J Mol Sci .
Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases
Front Mol Neurosci .
Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains
Front Neurosci .
Sign up to view the full profile.
Explore areas of focus, current work, and collaboration capabilities.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Company
AboutBlogCareersHalo Awards
Support
FAQsHelp center
Contact us
Sponsors
Customer stories
Privacy PolicyTerms of Service
© 2026 Halo Cures, Inc.